Hospital Corporation of China Limited (HKG:3869)
Hong Kong · Delayed Price · Currency is HKD 3.400
0.00 (0.00%)
Aug 4, 2026, 9:54 AM HKT
HKG:3869 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,471 | 1,442 | 1,428 | 1,143 | 520.29 | |
Revenue Growth | 1.99% | 1.02% | 24.92% | 119.68% | 30.33% |
Cost of Revenue | 1,203 | 1,166 | 1,188 | 992.07 | 306.06 |
Gross Profit | 267.62 | 275.82 | 239.36 | 150.88 | 214.23 |
Selling, General & Admin | 121.17 | 109.12 | 130.8 | 95.5 | 97.88 |
Other Operating Expenses | 25.81 | -13.53 | -17.05 | 18.66 | 17.91 |
Operating Expenses | 146.97 | 95.58 | 113.75 | 114.16 | 115.78 |
Operating Income | 120.65 | 180.24 | 125.61 | 36.71 | 98.44 |
Interest Expense | -101.91 | -111.07 | -2.46 | -4.91 | -6.09 |
Interest & Investment Income | 7.32 | 10.53 | 9.74 | 8.99 | 6.73 |
Currency Exchange Gain (Loss) | - | - | - | 5.61 | -13.35 |
Other Non Operating Income (Expenses) | 159.91 | -7.51 | -141.84 | -0.06 | -1.32 |
EBT Excluding Unusual Items | 185.97 | 72.18 | -8.95 | 46.35 | 84.42 |
Impairment of Goodwill | - | - | - | -362.82 | -141.27 |
Gain (Loss) on Sale of Investments | 0.63 | 1.62 | 2.23 | 5.72 | 5.76 |
Gain (Loss) on Sale of Assets | - | - | - | -0.65 | -0.14 |
Asset Writedown | - | - | - | -97.46 | -410.71 |
Other Unusual Items | - | - | 222.92 | -123.76 | 12.84 |
Pretax Income | 186.59 | 73.81 | 216.2 | -532.63 | -449.1 |
Income Tax Expense | 47.56 | 47.48 | 47.86 | -4.03 | -86.71 |
Earnings From Continuing Operations | 139.03 | 26.33 | 168.34 | -528.6 | -362.4 |
Net Income to Company | 139.03 | 26.33 | 168.34 | -528.6 | -362.4 |
Minority Interest in Earnings | -2.61 | -52.42 | -36.96 | 47.65 | 81.69 |
Net Income | 136.42 | -26.09 | 131.38 | -480.95 | -280.71 |
Net Income to Common | 136.42 | -26.09 | 131.38 | -480.95 | -280.71 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 136 | 137 | 137 | 138 | 138 |
Shares Outstanding (Diluted) | 201 | 137 | 202 | 138 | 138 |
Shares Change | 46.79% | -32.20% | 46.29% | - | - |
EPS (Basic) | 1.00 | -0.19 | 0.96 | -3.48 | -2.03 |
EPS (Diluted) | 0.35 | -0.19 | 0.21 | -3.48 | -2.03 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 135.7 | 196.87 | 68.7 | 127.55 | 120.65 |
Free Cash Flow Per Share | 0.67 | 1.44 | 0.34 | 0.92 | 0.87 |
Gross Margin | 18.19% | 19.12% | 16.77% | 13.20% | 41.17% |
Operating Margin | 8.20% | 12.50% | 8.80% | 3.21% | 18.92% |
Profit Margin | 9.27% | -1.81% | 9.20% | -42.08% | -53.95% |
Free Cash Flow Margin | 9.22% | 13.65% | 4.81% | 11.16% | 23.19% |
EBITDA | 174.98 | 236.54 | 187.6 | 95.45 | 136.2 |
EBITDA Margin | 11.89% | 16.40% | 13.14% | 8.35% | 26.18% |
D&A For EBITDA | 54.34 | 56.31 | 61.99 | 58.73 | 37.75 |
EBIT | 120.65 | 180.24 | 125.61 | 36.71 | 98.44 |
EBIT Margin | 8.20% | 12.50% | 8.80% | 3.21% | 18.92% |
Effective Tax Rate | 25.49% | 64.33% | 22.14% | - | - |